Proposed Medicare Pricing Changes Threatened Proton Centers
A new national payment policy could lead to lower reimbursement rates for independent proton therapy facilities.
Updated on Oct. 9, 2026 in Cancer
Live Poll
Should Medicare reimbursement rates for specialized cancer therapy favor hospitals over local independent treatment centers?
The Centers for Medicare & Medicaid Services has proposed a national pricing methodology that would reduce Medicare payments to freestanding proton therapy centers by nearly 30% in 2027. This shift in payment policy aims to standardize rates currently managed by individual contractors.
Why it matters
Proponents fear that if these reductions are implemented, up to one-third of the nation's independent proton therapy centers could face financial jeopardy. This change could also deter the future development of specialized radiotherapy facilities nationwide.
CMS proposed a national methodology for proton beam treatment services to address existing payment variations. The proposal directly affects the 53 freestanding centers operating across the United States.
The players
Centers for Medicare & Medicaid Services
The federal agency that administers the Medicare program and sets national payment policies for clinical services.
UF Health Proton Therapy Institute
A facility that provides specialized radiation treatment for cancer patients and has served 13,000 individuals since opening.
Ackerman Cancer Center
A medical provider that offers comprehensive oncology services and integrated proton therapy into its practice in 2015.
The details
The proposal replaces localized payment systems with a standardized national rate for proton beam delivery services. Building a standalone facility requires an investment of up to $250 million, and high Medicare patient volumes at centers like the UF Health Proton Therapy Institute and Ackerman Cancer Center make them sensitive to revenue shifts. CMS officials stated the intent is to address geographic payment disparities and recognize the specialized resources required for this treatment.
Timeline
1997: Ackerman Cancer Center was founded.
2006: UF Health Proton Therapy Institute opened.
September 28, 2026: Members of Congress sent a letter to the CMS Administrator opposing the plan.
November 1, 2026: A final CMS decision on the pricing plan is due.
2027: The proposed payment changes are set to take effect.
Health Landscape
This proposal marks a shift in how federal healthcare programs value highly specialized, capital-intensive cancer treatments. It follows a historical arc of efforts by regulators to centralize and standardize reimbursement methodologies for complex medical technologies.
Patients currently undergoing or planning proton therapy should monitor how these potential financial shifts might influence their local treatment site's operations. If you are concerned about your access to care, these coverage changes are a valid topic to discuss with your oncology team.
The takeaway
The proposed CMS policy highlights the tension between standardizing federal healthcare costs and supporting specialized, high-cost medical infrastructure. Patients should focus on maintaining open communication with their oncology care coordinators regarding any potential changes to center access or services.
Further reading
For broader context on oncology care delivery and federal policy, see our Cancer section.
Source note: This article includes information reported by Florida Times-Union.
Live Poll
Should Medicare reimbursement rates for specialized cancer therapy favor hospitals over local independent treatment centers?
